Equities analysts expect that Innospec Inc. (NASDAQ:IOSP) will announce earnings of $1.12 per share for the current quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Innospec’s earnings. Innospec posted earnings of $1.00 per share during the same quarter last year, which would indicate a positive year-over-year growth rate of 12%. The firm is scheduled to announce its next earnings results on Tuesday, August 6th.
On average, analysts expect that Innospec will report full-year earnings of $5.15 per share for the current financial year. For the next fiscal year, analysts forecast that the business will report earnings of $5.35 per share. Zacks’ EPS calculations are an average based on a survey of sell-side analysts that that provide coverage for Innospec.
Innospec (NASDAQ:IOSP) last announced its earnings results on Tuesday, May 7th. The specialty chemicals company reported $1.25 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.18 by $0.07. Innospec had a net margin of 6.08% and a return on equity of 14.92%. The company had revenue of $388.30 million during the quarter. During the same period in the prior year, the firm posted $1.02 earnings per share. The company’s revenue was up 7.7% on a year-over-year basis.
Shares of NASDAQ IOSP opened at $84.65 on Monday. Innospec has a 1-year low of $53.07 and a 1-year high of $88.84. The stock has a market capitalization of $2.09 billion, a price-to-earnings ratio of 17.53 and a beta of 1.28. The company has a quick ratio of 1.45, a current ratio of 2.28 and a debt-to-equity ratio of 0.25.
The firm also recently declared a Semi-Annual dividend, which was paid on Thursday, May 30th. Stockholders of record on Tuesday, May 21st were given a dividend of $0.50 per share. This represents a dividend yield of 1.18%. The ex-dividend date was Monday, May 20th. Innospec’s dividend payout ratio is 20.70%.
In other news, VP Brian Watt sold 2,000 shares of Innospec stock in a transaction that occurred on Thursday, May 30th. The shares were sold at an average price of $82.01, for a total transaction of $164,020.00. Following the completion of the sale, the vice president now owns 30,992 shares in the company, valued at approximately $2,541,653.92. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Patrick Williams sold 7,030 shares of Innospec stock in a transaction that occurred on Tuesday, March 12th. The stock was sold at an average price of $84.16, for a total transaction of $591,644.80. Following the sale, the chief executive officer now owns 186,579 shares of the company’s stock, valued at approximately $15,702,488.64. The disclosure for this sale can be found here. In the last quarter, insiders have sold 17,855 shares of company stock valued at $1,490,630. 1.62% of the stock is owned by corporate insiders.
Several large investors have recently modified their holdings of IOSP. Avestar Capital LLC acquired a new position in Innospec during the first quarter valued at approximately $66,000. US Bancorp DE grew its holdings in Innospec by 54.6% during the first quarter. US Bancorp DE now owns 1,764 shares of the specialty chemicals company’s stock valued at $147,000 after purchasing an additional 623 shares during the period. LS Investment Advisors LLC grew its holdings in Innospec by 173.5% during the fourth quarter. LS Investment Advisors LLC now owns 1,972 shares of the specialty chemicals company’s stock valued at $122,000 after purchasing an additional 1,251 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in Innospec by 27.5% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,986 shares of the specialty chemicals company’s stock valued at $123,000 after purchasing an additional 428 shares during the period. Finally, PNC Financial Services Group Inc. grew its holdings in Innospec by 74.6% during the first quarter. PNC Financial Services Group Inc. now owns 2,357 shares of the specialty chemicals company’s stock valued at $197,000 after purchasing an additional 1,007 shares during the period. Institutional investors own 93.34% of the company’s stock.
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels.
Read More: NASDAQ Stock Market Explained
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.